Catalys Pacific Fund, Lp - Net Worth and Insider Trading
Catalys Pacific Fund, Lp Net Worth
The estimated net worth of Catalys Pacific Fund, Lp is at least $117 Million dollars as of 2024-11-05. Catalys Pacific Fund, Lp is the 10% Owner of Mineralys Therapeutics Inc and owns about 8,644,579 shares of Mineralys Therapeutics Inc (MLYS) stock worth over $117 Million. Details can be seen in Catalys Pacific Fund, Lp's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Catalys Pacific Fund, Lp has not made any transactions after 2024-07-24 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Catalys Pacific Fund, Lp
Catalys Pacific Fund, Lp Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Catalys Pacific Fund, Lp owns 1 companies in total, including Mineralys Therapeutics Inc (MLYS) .
Click here to see the complete history of Catalys Pacific Fund, Lp’s form 4 insider trades.
Insider Ownership Summary of Catalys Pacific Fund, Lp
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| MLYS | Mineralys Therapeutics Inc | 2024-07-24 | 10 percent owner |
Catalys Pacific Fund, Lp Latest Holdings Summary
Catalys Pacific Fund, Lp currently owns a total of 1 stock. Catalys Pacific Fund, Lp owns 8,644,579 shares of Mineralys Therapeutics Inc (MLYS) as of July 24, 2024, with a value of $117 Million.
Latest Holdings of Catalys Pacific Fund, Lp
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MLYS | Mineralys Therapeutics Inc | 2024-07-24 | 8,644,579 | 13.54 | 117,047,600 |
Holding Weightings of Catalys Pacific Fund, Lp
Catalys Pacific Fund, Lp Form 4 Trading Tracker
According to the SEC Form 4 filings, Catalys Pacific Fund, Lp has made a total of 2 transactions in Mineralys Therapeutics Inc (MLYS) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Mineralys Therapeutics Inc is the sale of 550,000 shares on July 24, 2024, which brought Catalys Pacific Fund, Lp around $7 Million.
Insider Trading History of Catalys Pacific Fund, Lp
- 1
Catalys Pacific Fund, Lp Trading Performance
GuruFocus tracks the stock performance after each of Catalys Pacific Fund, Lp's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Catalys Pacific Fund, Lp is -10.33%. GuruFocus also compares Catalys Pacific Fund, Lp's trading performance to market benchmark return within the same time period. The performance of stocks bought by Catalys Pacific Fund, Lp within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Catalys Pacific Fund, Lp's insider trading performs compared to the benchmark.
Performance of Catalys Pacific Fund, Lp
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -6 | | | | | |
| Relative Return to S&P 500(%) | -0.76 | | | | | |
Catalys Pacific Fund, Lp Ownership Network
Ownership Network List of Catalys Pacific Fund, Lp
Ownership Network Relation of Catalys Pacific Fund, Lp
Catalys Pacific Fund, Lp Owned Company Details
What does Mineralys Therapeutics Inc do?
Who are the key executives at Mineralys Therapeutics Inc?
Catalys Pacific Fund, Lp is the 10 percent owner of Mineralys Therapeutics Inc. Other key executives at Mineralys Therapeutics Inc include director & Chief Executive Officer Jon Congleton , CFO & Chief Bus. Off. and Secy. Adam Scott Levy , and Chief Medical Officer David Malcom Rodman .
Mineralys Therapeutics Inc (MLYS) Insider Trades Summary
Over the past 18 months, Catalys Pacific Fund, Lp made 1 insider transaction in Mineralys Therapeutics Inc (MLYS) with a net sale of 550,000. Other recent insider transactions involving Mineralys Therapeutics Inc (MLYS) include a net sale of 142,377 shares made by Jon Congleton , a net sale of 232,341 shares made by David Malcom Rodman , and a net sale of 118,329 shares made by Adam Scott Levy .
In summary, during the past 3 months, insiders sold 26,028 shares of Mineralys Therapeutics Inc (MLYS) in total and bought 0 shares, with a net sale of 26,028 shares. During the past 18 months, 1,053,797 shares of Mineralys Therapeutics Inc (MLYS) were sold and 566,305 shares were bought by its insiders, resulting in a net sale of 487,492 shares.
Mineralys Therapeutics Inc (MLYS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Mineralys Therapeutics Inc Insider Transactions
Catalys Pacific Fund, Lp Mailing Address
Above is the net worth, insider trading, and ownership report for Catalys Pacific Fund, Lp. You might contact Catalys Pacific Fund, Lp via mailing address: 301 9-19 Hachiyama, Shibuya, Tokyo M0 150-0035.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
